Eyestem, a Bengaluru-based cell therapy company, has raised funding from Endiya Partners, a venture capital fund that focuses on investing in firms in technology, healthcare and life sciences.
Argus Partners advised
2021-05-26
Deal value: Confidential
This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.
No comments yet: share your views